Theranos: A Rise and Fall of a Medical Technology Company

Theranos was a medical technology company that promised to revolutionize the healthcare industry with its innovative blood-testing technology. Founded in 2003 by Elizabeth Holmes, the company's mission was to make lab testing faster, cheaper, and more accessible to people around the world.

Elizabeth Holmes dropped out of Stanford University to start Theranos, and the company quickly gained attention from investors and the media. The company's valuation soared to $9 billion, making Holmes one of the youngest self-made billionaires in the world.

Theranos claimed to have developed a machine called the Edison that could run hundreds of lab tests from a single drop of blood. The machine was touted as a game-changer in the healthcare industry, with the potential to make lab testing faster and more affordable.

A fresh viewpoint: Marchant Calculating Machine Company

Theranos was a healthcare technology company founded in 2003 by Elizabeth Holmes, who was just 19 years old at the time. She was a college dropout.

Elizabeth Holmes was a charismatic leader who convinced investors to back her company with promises of revolutionizing the blood-testing industry. She claimed that Theranos's technology could run a wide range of tests with just a few drops of blood.

Theranos's headquarters was in Palo Alto, California, where the company was able to attract top talent and secure significant funding.

Discover more: Does Insurance Cover Blood Transfusions

Elizabeth Holmes developed the idea of creating a patch that would test microscopic blood samples for infectious diseases and dose antibiotics for treatment during her first year at Stanford in 2003.

She even filed the necessary paperwork to acquire a patent for this idea.

This idea eventually gave rise to the business idea of Theranos, which aimed to make blood tests easier, faster, and cheaper by reducing the amount of blood needed for testing.

Patients would only need to provide a few drops of blood, collected with a specially designed blood collection pen, which would be analyzed in the company's mini-laboratory device called "Edison".

For your interest: Vodafone Idea

Theranos promised to challenge US market leaders like Labcorp and Quest Diagnostics, who use tubes of blood for tests while the results take several days.

Holmes' business idea promised billions in sales.

Theranos claimed to have developed devices to automate and miniaturize blood tests using microscopic blood volumes, including the "nanotainer" and the "Edison" analysis machine.

Holmes dropped out of Stanford and used her parents' saved education money as seed money for Theranos. She convinced her professor, Channing Robertson, of her idea and recruited him as the first board member.

Robertson helped Holmes connect with venture capitalists, and she raised $6 million in capital by the end of 2004. Initially, the company operated without a corporate website or press releases.

Holmes started to gain media attention in 2013, becoming a media star and celebrated visionary. She appeared on the cover of Fortune, Forbes, and Inc.

Theranos entered into a partnership with US drugstore chain Walgreens in 2015, offering the company's tests in over 40 shops. Holmes promised that Theranos blood tests would soon be available within 5 miles of every American household.

Holmes claimed that the tests were being used by the US military in their medivac helicopters, a claim she only recanted when questioned by investigators under oath.

On a similar theme: Someone Used My Debit Card on Cash App

Theranos was able to attract a powerful circle of supporters, thanks in large part to the efforts of its founder, Elizabeth Holmes.

Channing Robertson, a Stanford professor, was one of Holmes' earliest and most important advocates. He became her mentor and the first board member at Theranos, helping the company gain scientific credibility externally.

George Shultz, the former US Secretary of State, joined the Theranos board in 2011, bringing with him a network of influential connections. This influx of high-profile board members continued over the next few years, with notable additions including Henry Kissinger and Richard Kovacevich.

Walmart's founding Walton family invested $150 million in Theranos, while media mogul Rupert Murdoch put in over $120 million. Former Secretary of Education Betsy DeVos also contributed $100 million to the company.

These investors ultimately lost their investments when Theranos collapsed, and Holmes' former business partner, Ramesh Balwani, was also charged with fraud.

Explore further: Liz Holmes

Theranos moved from 3200 Hillview Ave to the former Facebook headquarters at 1601 S. California Ave in June 2012.

The company's headquarters relocated again to 1701 Page Mill Road, Palo Alto, California, where it paid a $1 million per month lease for the Stanford Research Park building by 2017.

Theranos had laboratories in Newark, California, and Scottsdale, Arizona.

In 2017, the company vacated its Page Mill headquarters, moving remaining staff into the Newark, California, laboratories.

Worth a look: Rayonier Inc Headquarters

Elizabeth Holmes was the CEO of Theranos from its incorporation in 2003 until 2018. She recruited Channing Robertson, a chemical-engineering professor at Stanford, to be a technical advisor and the company's first board member.

Holmes's then-boyfriend Sunny Balwani joined the company as its president and chief operating officer in 2009. Balwani left his position in May 2016.

The company's board of directors was criticized for consisting mainly of directors with diplomatic or military backgrounds. This included William Perry, a former U.S. Secretary of Defense, and Jim Mattis, a General in the USMC.

Theranos announced its medical advisory board in April 2016, which included members with relevant biomedical expertise such as Susan A. Evans, a past president of the American Association for Clinical Chemistry.

The company's board of directors in May 2016 included:

The company's board of directors was restructured in January 2017, with the departure of Riley Bechtel.

The Company has a rigorous hiring process that involves multiple rounds of interviews with various team members. This ensures that each new hire is a great fit for the team.

The first round of interviews is typically conducted by a member of the recruitment team, who assesses the candidate's skills and experience. They usually ask behavioral questions to gauge the candidate's problem-solving abilities.

The candidate who passes the first round is then invited to a skills assessment, where they are presented with real-world challenges to solve. This helps the Company evaluate their technical skills and creativity.

After completing the skills assessment, the candidate is invited to a final round of interviews with the hiring manager. This is an opportunity for the candidate to ask questions and learn more about the role and the Company culture.

The entire hiring process typically takes around 2-3 weeks, depending on the position and the availability of the team members involved.

Intriguing read: JAK Members Bank

Theranos had a few notable partnerships that didn't quite work out as planned. The company invested $350 million into retrofitting 800 locations with clinics that would offer in-store blood tests, but the deal was terminated in 2015.

Walgreens was one of Theranos' biggest partners, but it didn't last long. They invested $140 million in the partnership, which was reportedly used to offer in-store blood tests at more than 40 locations.

Theranos also partnered with the Cleveland Clinic to test its technology and decrease the cost of lab tests. This partnership was announced in March 2015.

The Food and Drug Administration approved the use of Theranos' fingerstick blood testing device for the herpes simplex virus (HSV-1) outside a clinical laboratory setting in July 2015.

A unique perspective: T K Group of Industries

Elizabeth Holmes' claims about Theranos' revolutionary blood-testing technology were later discovered to be fraudulent. This led to a series of consequences that ultimately led to the downfall of the company.

In 2018, the SEC charged Holmes and former company president Ramesh "Sunny" Balwani with fraud, and they were eventually imprisoned. This was a significant turning point for the company, marking the beginning of the end.

The HHS-OIG previously excluded Theranos President, Ramesh Balwani, for 90 years, following his conviction for conspiracy to commit wire fraud against Theranos's patients and investors. This exclusion prohibited payment for any health care item or service furnished, ordered, or prescribed by Balwani.

Elizabeth Holmes' net worth reportedly dropped from $4.5 billion to nothing by June 2016, a staggering loss that reflects the severity of the consequences she faced.

Here are some key takeaways about the exposure and downfall of Theranos:

Theranos announced it would cease operations on September 4, 2018.

The company's remaining employees had been laid off just a few days earlier, on August 31. Most of them had already left the company by then.

Theranos general counsel and new CEO David Taylor, along with a few support staffers, remained on payroll for a short time after the layoffs.

Any equity investments in the company became worthless after the shutdown.

Theranos transferred its patents to Fortress Investment Group on September 12, in exchange for the company's cash assets to be distributed to creditors.

Theranos, the infamous Silicon Valley startup, has been the subject of intense media scrutiny. A book-length treatment of the company's story was published by John Carreyrou in May 2018, titled Bad Blood: Secrets and Lies in a Silicon Valley Startup.

The book was later adapted into a film, with Jennifer Lawrence set to star as Elizabeth Holmes, the company's charismatic CEO. However, Lawrence announced she would no longer be involved with the project in November 2022.

A podcast and documentary series called The Dropout, released by ABC News Nightline in January 2019, also explored the Theranos story. The series was later adapted into a miniseries, starring Amanda Seyfried as Holmes, which premiered on Hulu in March 2022.

The Inventor: Out for Blood in Silicon Valley, a documentary film directed by Alex Gibney, made its debut at the Sundance Film Festival in January 2019 and was later released on HBO platforms.

Intriguing read: Pleasant Valley Wine Company

Theranos was founded in 2003 by Elizabeth Holmes, who was just 19 years old at the time.

Elizabeth Holmes dropped out of Stanford University to pursue her vision of revolutionizing healthcare through blood testing.

Theranos raised over $700 million from investors, including Larry Ellison and Betsy DeVos.

The company's valuation reached $9 billion in 2014, making Elizabeth Holmes one of the youngest self-made billionaires in the world.

Theranos claimed to have developed a blood-testing technology that could perform hundreds of tests with just a few drops of blood.

The company's technology was supposed to be more accurate and faster than traditional lab tests.

Theranos had partnerships with major retailers, including Walgreens, to offer its blood-testing services.

The company's products were used by over 1 million people in 2014.

Theranos was shut down in 2018 after a series of investigations and lawsuits revealed that its technology was not as effective as claimed.

Elizabeth Holmes was charged with fraud in 2018 and is awaiting trial.

Here's an interesting read: Elizabeth Arden, Inc.